Menora Mivtachim Holdings’s Eloxx Pharmaceuticals, Inc. Common Stock ELOX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-52,355
Closed -$62.8K 101
2023
Q4
$62.8K Hold
52,355
﹤0.01% 96
2023
Q3
$252K Hold
52,355
﹤0.01% 92
2023
Q2
$204K Hold
52,355
﹤0.01% 93
2023
Q1
$131K Hold
52,355
﹤0.01% 90
2022
Q4
$95.3K Hold
52,355
﹤0.01% 61
2022
Q3
$356K Hold
52,355
0.01% 58
2022
Q2
$565K Hold
52,355
0.01% 59
2022
Q1
$1.17M Hold
52,355
0.02% 52
2021
Q4
$1.48M Hold
52,355
0.02% 53
2021
Q3
$3.41M Hold
52,355
0.05% 52
2021
Q2
$4.17M Hold
52,355
0.06% 52
2021
Q1
$6.95M Hold
52,355
0.11% 49
2020
Q4
$8.34M Hold
52,355
0.15% 47
2020
Q3
$5.51M Hold
52,355
0.12% 47
2020
Q2
$6.34M Hold
52,355
0.16% 46
2020
Q1
$4.11M Hold
52,355
0.11% 46
2019
Q4
$15.4M Sell
52,355
-120
-0.2% -$24.2K 0.37% 48
2019
Q3
$9.49M Sell
52,475
-2,586
-5% -$736K 0.23% 54
2019
Q2
$22M Buy
55,061
+8,000
+17% +$3.37M 0.59% 49
2019
Q1
$22M Hold
47,061
0.59% 56
2018
Q4
$22.6M Hold
47,061
0.65% 62
2018
Q3
$32.1M Buy
47,061
+4,227
+10% +$2.71M 0.87% 53
2018
Q2
$29.2M Buy
+42,834
New +$27.8M 0.83% 45

Other funds holding ELOX

Menora Mivtachim Holdings's ELOX Position: Q1 2024 in Review

Menora Mivtachim Holdings sold out of Eloxx Pharmaceuticals, Inc. Common Stock (ELOX) in Q1 2024, closing a stake of 52,355 shares — an estimated $62.8K sold.

Menora Mivtachim Holdings first reported a position in ELOX in Q2 2018 and held it in 23 quarters. The position peaked at $32.1M in Q3 2018. 1 fund tracked by Wall St. Rank holds ELOX as of Q1 2024.

  • Menora Mivtachim Holdings reported no remaining Eloxx Pharmaceuticals, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Menora Mivtachim Holdings sold 52,355 Eloxx Pharmaceuticals, Inc. Common Stock shares in Q1 2024, an estimated $62.8K.
  • Menora Mivtachim Holdings first reported a position in Eloxx Pharmaceuticals, Inc. Common Stock in Q2 2018 and held it in 23 quarters.
  • Menora Mivtachim Holdings's Eloxx Pharmaceuticals, Inc. Common Stock position peaked at $32.1M in Q3 2018.
  • 1 fund tracked by Wall St. Rank held Eloxx Pharmaceuticals, Inc. Common Stock as of Q1 2024.

Based on Menora Mivtachim Holdings's 13F filing for Q1 2024, filed 13 May 2024.